1. Home
  2. PLAB vs GPCR Comparison

PLAB vs GPCR Comparison

Compare PLAB & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • GPCR
  • Stock Information
  • Founded
  • PLAB 1969
  • GPCR 2016
  • Country
  • PLAB United States
  • GPCR United States
  • Employees
  • PLAB N/A
  • GPCR N/A
  • Industry
  • PLAB Semiconductors
  • GPCR
  • Sector
  • PLAB Technology
  • GPCR
  • Exchange
  • PLAB Nasdaq
  • GPCR Nasdaq
  • Market Cap
  • PLAB 1.4B
  • GPCR 1.2B
  • IPO Year
  • PLAB 1987
  • GPCR 2023
  • Fundamental
  • Price
  • PLAB $22.59
  • GPCR $33.56
  • Analyst Decision
  • PLAB Strong Buy
  • GPCR Strong Buy
  • Analyst Count
  • PLAB 2
  • GPCR 8
  • Target Price
  • PLAB $31.00
  • GPCR $69.57
  • AVG Volume (30 Days)
  • PLAB 616.0K
  • GPCR 835.9K
  • Earning Date
  • PLAB 12-10-2025
  • GPCR 11-06-2025
  • Dividend Yield
  • PLAB N/A
  • GPCR N/A
  • EPS Growth
  • PLAB N/A
  • GPCR N/A
  • EPS
  • PLAB 1.77
  • GPCR N/A
  • Revenue
  • PLAB $856,152,000.00
  • GPCR N/A
  • Revenue This Year
  • PLAB N/A
  • GPCR N/A
  • Revenue Next Year
  • PLAB $3.87
  • GPCR N/A
  • P/E Ratio
  • PLAB $12.68
  • GPCR N/A
  • Revenue Growth
  • PLAB N/A
  • GPCR N/A
  • 52 Week Low
  • PLAB $16.46
  • GPCR $13.22
  • 52 Week High
  • PLAB $31.60
  • GPCR $40.06
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 43.98
  • GPCR 62.70
  • Support Level
  • PLAB $21.00
  • GPCR $30.70
  • Resistance Level
  • PLAB $24.40
  • GPCR $34.50
  • Average True Range (ATR)
  • PLAB 0.82
  • GPCR 1.79
  • MACD
  • PLAB -0.23
  • GPCR 0.17
  • Stochastic Oscillator
  • PLAB 39.49
  • GPCR 87.11

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: